Bangalore Cancer Centre Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 18-12-2024
- Paid Up Capital ₹ 3.50 Cr
as on 18-12-2024
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 3.20 Cr
as on 18-12-2024
- Satisfied Charges ₹ 5.62 Cr
as on 18-12-2024
- Revenue 18.70%
(FY 2019)
- Profit 37.93%
(FY 2019)
- Ebitda 3509.91%
(FY 2019)
- Net Worth -24.15%
(FY 2019)
- Total Assets 7.86%
(FY 2019)
About Bangalore Cancer Centre
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.50 Cr.
The company currently has active open charges totaling ₹3.20 Cr. The company has closed loans amounting to ₹5.62 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kandhappan Velavan, Ponmalar, and Rajendran Vijayarani serve as directors at the Company.
- CIN/LLPIN
U85100KA2009PTC050359
- Company No.
050359
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2009
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bangalore Cancer Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kandhappan Velavan  | Managing Director | 10-Jul-2009 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ponmalar | Director | 10-Jul-2009 | Current |
| Rajendran Vijayarani | Additional Director | 07-Jul-2011 | Current |
Financial Performance of Bangalore Cancer Centre.
Bangalore Cancer Centre Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 18.7% increase. The company also saw a substantial improvement in profitability, with a 37.93% increase in profit. The company's net worth observed a substantial decline by a decrease of 24.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bangalore Cancer Centre?
In 2019, Bangalore Cancer Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Erode Cancer Centre Private LimitedActive 19 years 5 monthsKandhappan Velavan and Ponmalar are mutual person
Velmalar Holdings Private LimitedActive 3 years 2 monthsKandhappan Velavan and Ponmalar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 17 Aug 2021 | ₹2.00 M | Open |
Others Creation Date: 23 Nov 2016 | ₹3.00 Cr | Open |
Others Creation Date: 28 Aug 2020 | ₹1.68 M | Satisfied |
How Many Employees Work at Bangalore Cancer Centre?
Unlock and access historical data on people associated with Bangalore Cancer Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bangalore Cancer Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bangalore Cancer Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
